A new 'Godzilla' fat-jab could rival Mounjaro, helping users shed a fifth of their body weight, while improving blood ...
New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and ...
The investigational monoclonal antibody, VYD2311, (Invivyd) met all primary and key secondary endpoints in the phase 3 LIBERTY study. It showed safety and tolerability superior to an mRNA-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results